HIV/AIDS
Findings from Johns Hopkins University broaden understanding of HIV/AIDS
Published in AIDS Weekly, May 5th, 2008
According to recent research published in the journal Antiviral Therapy, "Antiretroviral therapy including tipranavir boosted with ritonavir (TPV/r) has shown superior viral suppression and immunological response compared with comparator ritonavir-boosted protease inhibitor (CPI/r) regimens in treatment-experienced HIV-1-infected patients. This study assesses the influence of adverse events (AEs) on health-related quality of life (HRQOL) and change in HROOL in patients treated with TPV/r versus CPI/r regimens."
"Changes in HRQOL over 48 weeks were assessed using Medical Outcomes Study HIV Health Survey (MOS-HIV) data combined from two randomized, open-label,...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (2008-05-05)
More Articles from AIDS Weekly
- Peripheral Neuropathy
Study shows common vitamin and other micronutrient supplements reduce risks of TB recurrence - Cryptococcosis
Researchers from Chang Gung Memorial Hospital detail new studies and findings in the area of cryptococcosis - HIV/AIDS
Genetic Immunity Announces Data Related to the DermaVir Nanomedicine Patch in the Journal of Immunology - HIV/AIDS
New findings from J. Sterjovski and co-authors describe advances in HIV/AIDS - HIV/AIDS
New HIV/AIDS data have been reported by J.M. Leung and co-authors - HIV/AIDS
New HIV/AIDS research has been reported by scientists at INSERM - More from this issue of AIDS Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
